Sellwell Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Na, Madhya Pradesh, India, established in 1989.
1989 Na, Madhya Pradesh, India Active
Last Updated:
Access Report
About Sellwell Pharmaceuticals Limited

Sellwell Pharmaceuticals Limited, a active public limited company, was established on 14 August 1989 in Na, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1989PLC005424. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.57 M.

Formerly known as Sellwell Pharmaceuticals Private Limited. It upholds a compliant status. Employing 29 professional, Its leadership includes Harish Kumar Matlani (Director), Muskan Karamchandani (Director), Kamal Karamchandani (Managing Director). Past directors included Lekhraj Karamchandani, Hira Karamchandani, Harish Kumar Matlani. It holds ₹6.58 Cr open charges and ₹3.36 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 92-Sectore Esanwer Road Indore, Na, Madhya Pradesh.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP1989PLC005424

  • Registration Number

    005424

  • Incorporation Date

    14 August 1989

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹5.57 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 5.57 M
  • Company Age 36 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 6.58 Cr
  • Satisfied Charges ₹ 3.36 Cr
  • Revenue Growth **** -20.58%
  • Profit Growth **** 22.76%
  • Ebitda **** -34.91%
  • Net Worth 8.78%
  • Total Assets -7.46%
Company report

Sellwell Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Sellwell Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sellwell Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Harish Kumar Matlani Director 28 Mar 2019 Current
Muskan Karamchandani Director 23 Mar 2012 Current
Kamal Karamchandani Managing Director 23 Mar 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 05 Dec 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 31 Mar 2012 Past
Pramod Abcsdd Additional Director 29 Sep 2012 Past
Pramod Abcsdd Director 19 Jul 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sellwell Pharmaceuticals.

Sellwell Pharmaceuticals Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 20.58% decrease. The company also saw a substantial improvement in profitability, with a 22.76% increase in profit. The company's net worth moved up by a moderate rise of 8.78%.

Sellwell Pharmaceuticals revenue growth over time
Sellwell Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -20.58%
*******
*******
*******
*******
Revenue from Operations
*******
 -21.26%
*******
*******
*******
*******
Total Assets
*******
 -7.46%
*******
*******
*******
*******
Profit or Loss
*******
 22.76%
*******
*******
*******
*******
Net Worth
*******
 8.78%
*******
*******
*******
*******
EBITDA
*******
 -34.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sellwell Pharmaceuticals?

In 2024, Sellwell Pharmaceuticals had a promoter holding of 99.91% and a public holding of 0.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹65,755,000.00

Satisfied Charges

₹33,623,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 6.58 Cr
Latest Charge Details
Date Lender Amount Status
02 Jul 2024 Axis Bank Limited ₹0.43 M Open
28 Jun 2021 Axis Bank Limited ₹1.28 M Open
28 Nov 2016 Axis Bank Limited ₹6.41 Cr Open
27 May 2016 Others ₹2.50 M Satisfied
06 Jan 2015 Cosmos Co-Operative Bank Ltd. ₹1.30 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sellwell Pharmaceuticals?

Sellwell Pharmaceuticals has a workforce of 29 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sellwell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sellwell Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sellwell Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Axis Bank Limited of Rs. 6.41 Cr registered on 28 Nov 2016 with Charge ID 100076668 was modified on 22 Sep 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Sellwell Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100953152 was registered on 02 Jul 2024. was documented.

  • Balance Sheet

    The activity Sellwell Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 0.13 Cr with Charge ID 100466086 was registered on 28 Jun 2021. was completed.

  • Director Appointment

    Harish Kumar Matlani was appointed as a Director was appointed as a Director on 28 Mar 2019 & has been associated with this company since 7 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sellwell Pharmaceuticals Limited?

The CIN of Sellwell Pharmaceuticals Limited is U24232MP1989PLC005424.

Where is Sellwell Pharmaceuticals Limited headquartered?

Sellwell Pharmaceuticals Limited is headquartered at 92-Sectore Esanwer Road Indore, Na, Madhya Pradesh.

When was Sellwell Pharmaceuticals Limited incorporated?

Sellwell Pharmaceuticals Limited was incorporated on 14 August 1989.

Who are the current directors of Sellwell Pharmaceuticals Limited?

The current directors of Sellwell Pharmaceuticals Limited are

What is the primary industry of Sellwell Pharmaceuticals Limited?

The primary industry of Sellwell Pharmaceuticals Limited is Manufacturing.

Is Sellwell Pharmaceuticals Limited a listed company?

Sellwell Pharmaceuticals Limited is unlisted.

What is the capital structure of Sellwell Pharmaceuticals Limited?

The authorized capital of Sellwell Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹5.57 M.

What is the compliance status of Sellwell Pharmaceuticals Limited?

The compliance status of Sellwell Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available